Abstract Allicin is one of the most effective compounds isolated from garlic showing antibacterial activity. Determination of MIC alone or in combination with cefazolin/oxacillin against Staphylococcus spp. or with cefoperazone against Pseudomonas aeruginosa showed that allicin alone did not have good antibacterial activity (MIC 90 Ͼ512 m g/ml) but it facilitated antibacterial activity of all three b -lactams tested at subinhibitory concentrations. In the presence of 1/8 to 1/2 the MIC of allicin, the MIC 90 values of cefazolin, oxicillin, and cefoperazone were reduced by 4ϳ128, 32ϳ64, and 8ϳ16 fold, respectively. Thus, allicin-b -lactam combinations offer promise of clinical utility especially if synergism is demonstrated by in vivo experimental studies.
Introduction

Staphylococcus aureus, Staphylococcus epidermidis and
Pseudomonas aeruginosa are significant clinical pathogens [1ϳ3] . With the increasing use of antibiotics in the clinic, multidrug resistant strains become frequently encountered [4ϳ6] , making treatment with a single agent more and more difficult to cure infections. Attempts have been made to cope with this problem by combination therapy [7] .
Garlic is the bulb of Allium sativum, which is a Liliaceae Allium plant [8ϳ11] . It is claimed to have antiseptic, antiinflammatary, and antiflatulent properties. Allicin is the main effective antibacterial ingredient of garlic [12] . In the present study, in vitro antibacterial activity of allicin alone and in combination with cefazolin or oxacillin against Staphylococci spp. or with cefoperazone against P. aeruginosa was investigated. Synergistic effect was observed between allicin and each of the three b-lactams studied. 
Materials and Methods
Strains and Agents
Checkerboard Microdilution Assay
The initial concentration for each bacterial suspension was 1.5ϫ10 5 cfu/ml. The final drug concentration ranged 1024ϳ1.0 mg/liter for allicin, 32ϳ0.031 mg/liter for cefazolin and oxacillin, and 128ϳ0.125 mg/liter for cefoperazone. Two-fold dilutions of each drug or drug combination were tested. Results were read after plates were incubated at 37°C for 24 hours. MIC 90 and MIC 50 were determined as the lowest concentration of the drugs (alone or in combination) that inhibited growth by 90 or 50% respectively of the strains tested [13] . The fractional inhibitory concentration (FIC) index is defined as the sum of the MIC of each drug when used in combination divided by the MIC of the drug used alone. Synergistic effect was recorded when FIC indexesՅ0.5; partial synergy when FICϾ0.5 but Ͻ1.0; additive when FICϭ1.0; indifferent when FICϾ1.0 but Ͻ4.0, and antagonistic when FICՆ4.0 [7] .
Results
Enhancement of Antibacterial Activity of Cefazolin and Oxacillin against S. aureus and S. epidermidis by Allicin
The results of the checkboard analysis are summarized in Table 1 . The MIC 90 s of cefazolin and oxacillin alone were 16 and 8.0 mg/liter, respectively with S. aureus, and 4.0 and 16 mg/liter, respectively with S. epidermidids. When allicin was added at 1/8 or 1/4 MIC to the b-lactam regimens, the MIC 90 of cefazolin decreased by 128-and 4-fold, respectively with S. aureus and S. epidermidis while that of oxacillin decreased by 64-and 32-fold with S. aureus and S. epidermidis, respectively. Synergism was observed for each b-lactam antibiotics/allicin combination since all FIC values for MIC 90 were less than 0.5 (Table 1) . FIC value distribution among 40 Staphylococcus spp. was presented in Fig. 1 . Fifty-five to seventy-five percent of isolates had FIC values less than 0.5, 20ϳ40% isolates gave FIC between 0.5 and 1 among which most had values just above 0.5, and no indifferent or antagonism effect was observed.
The cumulative percent inhibition curve also showed improved activity of allicin and cefozolin combination when compared with either compound alone (Fig. 2) . Similar results were obtained with allicin and oxacillin combinations (data not shown). These data indicate that synergism may be the main reason for improved activity of 
Fig. 1 FIC index distribution of allicin combined with cefazolin/oxacillin against 20 each of clinical isolates of Staphylococcus aureus or Staphylococcus epidermidis.
ᮀ Allicinϩcefazolin to SA, allicinϩoxacillin to SA, allicinϩ cefazolin to SE, allicinϩoxacillin to SE. allicin and cefazolin or oxacillin combinations against Staphylococci.
Enhancement of Antibacterial Activity of Cefoperazone by Allicin against P. aeruginosa
The MICs of cefoperazone were 4-fold higher for drug resistant strains, which exceed the blood levels attainable for clinically recommended dosage. When combined with 1/4ϳ1/2 MIC of allicin, the MICs of cefopeazone reduced by 8ϳ32 fold over that of cefoperazone used alone (Table  2) , making drug-resistant strains treatable with clinically recommended dosage. Synergy and partial synergy was evident with the allicin -cefoperazone combination because FIC values ranged between 0.28ϳ0.56 (Table 2 ) and because 41ϳ64% of isolates had FIC less than 0.5, 36ϳ41% gave FIC values between 0.5 and 1, and no resistant and only less than 18% of susceptible isolates had FIC values of 1 (Fig. 3) . No isolate gave a FIC value of more than 1 (Fig. 3) . The cumulative percent inhibition curve also demonstrated that the combination regimen had much better activity than either compound alone with both resistant (Fig. 4) and susceptible isolates (not shown).
Discussion
Infections caused by Gram-positive cocci and P. aeruginosa are increasing both in hospitals and in general community [1ϳ6, 14ϳ18]. The efficacy of many antibiotics for treatment of severe infections has become quite limited due to the development of resistance. Allicin, one of the main effective antibacterial ingredients isolated from garlic, has also shown little adverse reaction, no antigenicity, and some immuno-modulation activity [19, 20] . Many published data indicate that allicin has certain in vitro antibacterial activity but the MICs are often relatively high, limiting its clinical utility [21ϳ23]. Consistent with these previous reports, our data also show relatively poor activity against all three bacterial species tested when allicin is used alone. Little difference in allicin MIC was observed between susceptible and resistant isolates of P. aeruginosa but the MIC with P. aeruginosa was slightly lower than with Staphylococci. When allicin was combined with cefazolin, oxacillin, or cefoperazone, it stimulated the activities of these b -lactam antibiotics in a synergistic fashion. The combined MIC 90 was brought down as many 337 as 128-fold for cefazolin -allicin combination with S. aureas compared with cefazolin alone at an allicin concentration of only 1/4 MIC. MICs with other allicin -blactam combinations against other bacteria tested were also reduced by 4-fold, making traditional dosages even effective against resistant strains of P. aeruginosa. These data encourage further studies with allicin plus other antimicrobial classes and in vivo animal experiments to validate this interesting finding before clinical test can move forward. Despite of lack of knowledge for the underlying mechanism of the synergistic effect of allicinb -lactam combinations, the potential for use of such combinations clinically is huge since it may be able to make some untreatable resistant infections treatable at currently recommended dosages that are often marginally effective against resistant strains when used alone. We are now testing other combinations and preparing animal work for validation of the synergistic effect.
